Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (441-450 of 574) with videos related to

Pageof 58
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2018
Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivorsLawson Eng, Dan Pringle, Jie Su, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Neural signatures and personalized neuromodulation in a subject experiencing context-dependent inhibitory control deficitsLayth S Mattar, Shraddha Shah, Lily S Chamakura, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trialPeter M Ellis, Frances A Shepherd, Michael Millward, et al.
Journal of the National Cancer Institute|October 2, 2014
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization studyAaron P Thrift, Nicholas J Shaheen, Marilie D Gammon, et al.
Cancer|September 7, 2019
Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma ConsortiumJessica L Petrick, Nan Li, Lesley A Anderson, et al.
Cancer Medicine|March 22, 2019
Impact of immigration status on health behaviors and perceptions in cancer survivorsSophia Y Liu, Lin Lu, Dan Pringle, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
International Journal of Cancer|June 30, 2026
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal CancerLucas Penny, Eric Yang Stutheit-Zhao, Birgitta E Michels, et al.
Pageof 58

Showing results (441-450 of 574) with videos related to

Sort By:
Pageof 58
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2018
Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivorsLawson Eng, Dan Pringle, Jie Su, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Neural signatures and personalized neuromodulation in a subject experiencing context-dependent inhibitory control deficitsLayth S Mattar, Shraddha Shah, Lily S Chamakura, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trialPeter M Ellis, Frances A Shepherd, Michael Millward, et al.
Journal of the National Cancer Institute|October 2, 2014
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization studyAaron P Thrift, Nicholas J Shaheen, Marilie D Gammon, et al.
Cancer|September 7, 2019
Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma ConsortiumJessica L Petrick, Nan Li, Lesley A Anderson, et al.
Cancer Medicine|March 22, 2019
Impact of immigration status on health behaviors and perceptions in cancer survivorsSophia Y Liu, Lin Lu, Dan Pringle, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
International Journal of Cancer|June 30, 2026
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal CancerLucas Penny, Eric Yang Stutheit-Zhao, Birgitta E Michels, et al.
Pageof 58